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Hypotension after reperfusion is a common occurrence during liver transplantation follow-
ing the systemic release of cold, hyperkalemic, and acidic contents of the liver allograft. 
Moreover, the release of vasoactive metabolites such as inflammatory cytokines and free 
radicals from the liver and mesentery, compounded by the hepatic uptake of blood, may 
also cause a decrement in systemic perfusion pressures. Thus, the postreperfusion syn-
drome (PRS) can materialize if hypotension and fibrinolysis occur concomitantly within 
5 min of reperfusion. Treatment of the PRS may require the administration of inotropes, 
vasopressors, and intravenous fluids to maintain hemodynamic stability. However, the 
occurrence of the PRS and its treatment with inotropes and calcium chloride may lead 
to dynamic left ventricular outflow tract obstruction (DLVOTO) precipitating refractory 
hypotension. Expedient diagnosis of DLVOTO with transesophageal echocardiography 
is extremely vital in order to avoid potential cardiovascular collapse during this critical 
period.
Keywords: postreperfusion syndrome, dynamic left ventricular outflow tract obstruction, systolic anterior motion 
of the mitral valve, paradoxical hypotension, transesophageal echocardiography, mitral regurgitation
INtRoDUCtIoN
Liver allograft reperfusion can be associated with significant cardiovascular instability and may 
require the administration of inotropes, vasopressors, and intravenous fluids, in order to avert 
cardiovascular collapse (1–8). The etiology of this cardiovascular depression is multifactorial and 
can result from several factors after unclamping of the portal vein, including: systemic release of 
the allograft preservative solution (cold and hyperkalemic fluid), blood-volume uptake by the liver 
allograft, the release of vasoactive mediators (such as inflammatory cytokines and free radicals), 
and acidic blood return from the liver and mesentery (1–5, 9, 10). The combination of these factors 
can result in the postreperfusion syndrome (PRS), a phenomenon initially described by Aggarwal 
et al. in 1987 (1–4). Significant hypotension may also occur after portal vein unclamping due to 
several other factors, such as: acute pulmonary embolus (from an inferior vena cava or portal vein 
thrombus), venous air embolism, acute right ventricular failure, dynamic left ventricular outflow 
tract obstruction (DLVOTO), and preload limitations (from torsion or obstruction of the inferior 
vena cava and massive blood loss) (1, 2, 6–8, 11). The etiology of the hypotension therefore has to be 
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investigated in a timely fashion, to ensure rapid and appropriate 
pharmacological therapy, and optimal patient outcomes.
We present a case of refractory hypotension precipitated by 
severe DLVOTO after liver reperfusion in a patient with left 
ventricular basal septal hypertrophy and a long anterior mitral 
leaflet. We also discuss the utility of transesophageal echocardi-
ography (TEE) as a diagnostic tool, and a guide for hemodynamic 
management in this dynamic setting.
Case RepoRt
A 54-year-old male with end-stage liver disease presented emer-
gently for orthotopic liver transplantation (OLT). Written consent 
was obtained from the patient for publication. The patient’s past 
medical history was significant for non-alcoholic steatohepatitis 
cirrhosis, hypertension, refractory ascites (requiring multiple 
paracenteses), hepatic encephalopathy, and hepatorenal syn-
drome. The patient had an extensive preoperative workup, which 
was inclusive of an esophagogastroduodenoscopy (EGD), a tran-
sthoracic echocardiogram, and an adenosine technetium-99m 
sestamibi stress single-photon emission computed tomography 
(SPECT) myocardial perfusion imaging study. Following the 
echocardiogram, results revealed hyperdynamic LV function 
(ejection fraction of 70–75%), normal LV size, normal right ven-
tricular size and function, mild tricuspid insufficiency, absence of 
intracardiac or transpulmonary shunts, and normal mitral valve 
(MV) leaflet morphology with trace mitral regurgitation. These 
normal echocardiographic findings suggested that a nuclear 
perfusion scan would be adequate to rule out hemodynamically 
significant obstructive coronary artery disease, as opposed to a 
dobutamine stress echocardiogram. Therefore, an adenosine 
stress test was performed 7 months prior to surgery. Results did 
not reveal any myocardial ischemia or prior myocardial injury, 
and demonstrated a hyperdynamic LV (ejection fraction of 83%). 
An EGD performed 2  months previously demonstrated the 
absence of esophageal variceal disease. Pertinent preoperative 
laboratory results included an elevated creatinine level of 1.5 mg/
dL (normal < 1.3 mg/dL), a low hematocrit level of 21% (nor-
mal > 39%), a low platelet count of 99 K/µL (normal > 150 K/
µL), an elevated INR of 1.7 (normal < 1.1), and an elevated PTT 
of 40 s (normal < 34 s).
The patient was taken into the operating room for OLT. The 
standard ASA monitors were placed, as well as a right radial 
arterial catheter for hemodynamic monitoring. Rapid-sequence 
induction of general anesthesia was performed, and intubation 
of the trachea was completed uneventfully. For hemodynamic 
monitoring, a right internal jugular venous oximetric pulmonary 
arterial catheter was inserted. Additionally, an 8.5 Fr rapid infu-
sion catheter was inserted into the right antecubital vein for 
volume administration. Intraoperative TEE evaluation (X7-2t 
transducer; Philips Healthcare, Andover, MA, USA) showed 
a hyperdynamic LV (ejection fraction of 65%), normal right 
ventricular systolic function, and normal biventricular sizes. 
The LV basal septum was mildly hypertrophied, measuring 
1.2  cm (normal <  1.1  cm). Furthermore, the MV had normal 
leaflet morphology on 2-dimensional and 3-dimensional assess-
ment, without any evidence of systolic anterior motion (SAM)/
DLVOTO. However, the anterior MV leaflet was elongated, 
measuring 2.6  cm, and the posterior leaflet length was 1.4  cm 
(Figures 1A–D).
Incision was performed followed by the drainage of 23 L of 
ascitic fluid. This resulted in systemic hypotension, which was 
successfully treated with phenylephrine and fluid boluses. A TEE 
assessment was performed and had similar findings to the base-
line examination. Significant blood loss was experienced during 
the pre-anhepatic phase and required transfusion of packed 
red blood cells. Point-of-care thromboelastometry was utilized 
intraoperatively to guide hemostatic therapy. This was achieved 
using the ROTEM® device (Tem International GmbH, Munich, 
Germany). A baseline ROTEM revealed deficiencies in the 
patient’s clotting factors, fibrinogen and platelets, but no evidence 
of fibrinolysis. To correct the coagulopathy, a combination of fresh 
frozen plasma, platelets, and cryoprecipitate were administered. 
Norepinephrine and vasopressin infusions were also initiated to 
support the patient’s systemic vascular resistance (SVR) in order 
to maintain adequate systemic perfusion pressures.
The anhepatic phase was associated with worsening hypoten-
sion after partial inferior vena cava clamping, which was treated 
with increased doses of norepinephrine and vasopressin infu-
sions. The liver allograft transplantation was performed using 
the piggyback technique. After completion of the cavo-caval 
piggyback anastomosis, the liver was retrogradely flushed, 
and the portal vein anastomosis was subsequently completed. 
Retrograde flushing of the allograft was performed to remove the 
preservative solution and hepatic metabolites before antegrade 
reperfusion. Immediately prior to reperfusion, the patient had a 
systemic blood pressure (BP) of 126/73 mmHg, and a heart rate 
(HR) of 95 beats/min. The patient was prophylactically treated 
for PRS immediately prior to reperfusion with fluids, 10  mcg 
of epinephrine, 500  mg of calcium chloride, and 100  mcg of 
phenylephrine.
Immediately after reperfusion, the patient became hypoten-
sive (systolic BP in the 70s), tachycardic (HR of 105 beats/min), 
and hyperfibrinolytic likely due to PRS (12, 13). Continued 
hemodynamic support was given using 20 mcg of epinephrine, 
500 mg of calcium chloride, 2 U of vasopressin, and aggressive 
volume resuscitation. This resulted in paradoxical hypotension 
(BP of 42/24 mmHg) and worsened tachycardia (HR of 114 beats/
min). Transesophageal echocardiographic assessment demon-
strated hyperdynamic LV function and an ejection fraction of 
60–65%. It also revealed SAM of the anterior MV leaflet, causing 
DLVOTO and severe posterolaterally directed mitral regurgita-
tion (Figures  2A–C). Based on the TEE findings, epinephrine 
and calcium chloride were discontinued. Boluses of esmolol and 
phenylephrine were administered. The patient was then placed in 
the Trendelenburg position and received a bolus of fluids. Manual 
compression of the abdominal aorta was also implemented to aug-
ment the SVR. This maneuver mimics aortic cross-clamp physiol-
ogy and can help improve BP and coronary perfusion. The aortic 
compression was performed carefully to avoid compression of the 
inferior vena cava, which would have caused a further decrement 
in the preload. The treatment approach described above resulted 
in a rapid improvement of the patient’s hemodynamics, which 
included the following parameters: a BP of 127/65 mmHg, and 
FIGURe 1 | (a) Pre-anhepatic 2D TEE midesophageal modified five-chamber view with color flow Doppler showing trace to mild mitral regurgitation. (B) Pre-
anhepatic 3D TEE en face view of the mitral valve visualized from the left atrial perspective indicating normal coaptation of the mitral leaflets during systole.  
(C) Pre-anhepatic 2D TEE modified five-chamber view in diastole demonstrating mild basal interventricular septal hypertrophy. (D) Pre-anhepatic 2D TEE modified 
five-chamber view in systole demonstrating the absence of risk factors for systolic anterior motion of the mitral valve leaflets. Absent risk factors include normal 
values for basal LV systolic dimension (4.3 cm), ratio of anterior to posterior mitral leaflet coapted length (1.86), and distance between the mitral coaptation point and 
the basal LV septum (2.8 cm). LV, left ventricle; RV, right ventricle; LA, left atrium; S, interventricular septum; ALC, anterolateral commissure; PMC, posteromedial 
commissure; A, anterior mitral valve leaflet; A1, first segment of the anterior mitral valve leaflet; A2, second segment of the anterior mitral valve leaflet; A3, third 
segment of the anterior mitral valve leaflet; P, posterior mitral valve leaflet; P1, first segment of the posterior mitral valve leaflet; P2, second segment of the posterior 
mitral valve leaflet; P3, third segment of the posterior mitral valve leaflet.
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a HR of 98 beats/min. An additional TEE examination indicated 
that both the SAM/DLVOTO and the mitral regurgitation had 
resolved. The remainder of the surgery was completed without 
any major hemodynamic derangements.
DIsCUssIoN
Liver reperfusion can be associated with significant hypotension 
resulting from a decrement in SVR and LV filling, an increment in 
PVR, myocardial depression, and bradyarrhythmias (1, 3–7, 14). 
This hemodynamic instability has predominantly been attributed 
to PRS, which has an occurrence rate of 12–81% during OLT (1–5, 
9, 10, 14). The PRS is characterized as the combination of two 
factors occurring within 5 min of reperfusion of the portal vein: 
(1) hypotension lasting at least 1 min after reperfusion (defined 
as a mean arterial pressure reduction of 30% or greater) and (2) 
fibrinolysis (1–4, 9, 12). Different approaches have been utilized 
to prevent PRS, and multiple treatment options exist to prevent 
cardiovascular collapse. Preventative measures primarily consist 
of prophylactically administering fluids and vasoactive medica-
tions such as inotropes (e.g., epinephrine), vasopressors (e.g., 
phenylephrine), or calcium chloride, and flushing the allograft 
before reperfusion to eliminate vasoactive mediators and the pre-
servative solution (1, 2, 9, 14, 15). However, other factors may be 
responsible for refractory hypotension after reperfusion, such as 
SAM and DLVOTO (6, 11). An increment in HR and contractility 
from the treatment of the PRS with inotropes, compounded by 
the vasodilatory state of reperfusion, and the relative hypovolemia 
(due to the allograft uptake of blood), may collectively precipitate 
the development of SAM/DLVOTO (6, 7, 16). If an expedient 
FIGURe 2 | (a) Postreperfusion 2D TEE midesophageal modified five-chamber view demonstrating systolic anterior motion of the anterior mitral valve leaflet causing 
severe left ventricular outflow tract obstruction. (B) Postreperfusion 3D TEE midesophageal modified five-chamber view demonstrating left ventricular outflow tract 
obstruction resulting from systolic anterior motion of the anterior mitral valve leaflet. (C) Postreperfusion 2D TEE midesophageal modified five-chamber view with 
color flow Doppler, demonstrating severe posterolateral mitral regurgitation caused by systolic anterior motion of the anterior mitral valve leaflet. LV, left ventricle; RV, 
right ventricle; LA, left atrium; RA, right atrium; A2, second segment of the anterior mitral valve leaflet; P2, second segment of the posterior mitral valve leaflet; S, 
interventricular septum; Arrow, coaptation defect between the mitral leaflets.
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diagnosis of SAM/DLVOTO is not made, circulatory collapse 
may develop. Thus, a critical diagnostic dilemma exists for the 
transplant anesthesiologist. This is especially true if intraopera-
tive TEE monitoring is not utilized.
Systolic anterior motion/DLVOTO is a common occurrence 
after MV repair with an incidence between 2 and 16% (17, 18). 
However, during liver transplantation, SAM/DLVOTO has been 
reported as the cause of hemodynamic compromise in a few cases 
where TEE was utilized for hemodynamic monitoring (6–8, 16, 
19, 20). Maslow et al. characterized several preoperative echocar-
diographic parameters that can lead to anterior displacement of 
the MV coaptation point and cause DLVOTO in systole after MV 
repair (17). These risk factors include long MV leaflets, anterior 
papillary muscle displacement, a small ratio of the anterior to pos-
terior MV leaflet coapted lengths (<1.3), a small LV basal systolic 
internal dimension (<4 cm), and a small distance between the 
MV coaptation point and the LV basal septum (<2.5 cm) (17). 
Other risk factors also exist, such as hypertrophic cardiomyopa-
thy, LV basal septal hypertrophy, and an aorto-mitral angle reduc-
tion (<120°) (18). The presence of these risks factors, along with 
tachycardia, increased LV contractility and a reduction in preload 
and afterload, may ultimately result in SAM/DLVOTO after MV 
repair (17, 18). Unfortunately, due to the rarity of SAM in OLT 
patients, echocardiographic predictors for the development of 
SAM/DLVOTO during liver transplantation have not been clearly 
delineated. However, the presence of a long anterior MV leaflet 
and LV basal septal hyperpertrophy predisposes a patient to SAM 
during reperfusion, especially when the internal dimension of the 
LV is significantly reduced. Furthermore, the presence of a normal 
baseline TEE does not guarantee that a patient would not develop 
SAM/DLVOTO during liver allograft reperfusion secondary to 
the dynamic nature of the reperfusion period.
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The patient described in this case report had a long anterior 
MV leaflet, and mild LV basal septal hypertrophy on his baseline 
intraoperative echocardiogram. After the onset of PRS, treat-
ment was altered slightly to use calcium chloride, epinephrine, 
and vasopressin. Paradoxical hypotension surfaced as a result 
and necessitated another TEE examination. Based on the TEE 
findings, SAM/DLVOTO was rapidly diagnosed as the root cause, 
and the anesthesiology team was able to formulate a favorable 
treatment plan. This plan included discontinuation of inotropes, 
administration of esmolol and phenylephrine, augmentation of 
preload through Trendelenburg positioning and administration 
of fluids, and augmentation of SVR by manually compressing 
the abdominal aorta. Using these approaches rapidly improved 
the patient’s hemodynamics and resulted in a favorable outcome. 
The occurrence of tachycardia, increased LV contractility and 
relative hypovolemia, compounded by the long anterior MV 
leaflet and LV basal septal hypertrophy, was a perfect setup for 
SAM/DLVOTO after reperfusion (6–8, 16, 19). The inability to 
accurately predict the severity of PRS, and the effect of inotropic 
support using conventional invasive hemodynamic monitor-
ing, makes TEE monitoring extremely beneficial. Without TEE 
monitoring, the timely diagnosis of SAM/DLVOTO would have 
been impossible. Thus, TEE complements standard invasive 
hemodynamic monitors during OLT.
In a previously published report, Aniskevich et al. described 
a similar case of SAM/DLVOTO after reperfusion. Their patient 
had concentric LVH and a normal preoperative dobutamine 
stress echocardiogram, with a maximal HR of 139 beats/min (6). 
The development of SAM/DLVOTO intraoperatively was likely 
caused by several factors: preexisting LVH (causing LV intracavi-
tary hypovolemia), intraoperative use of dopamine, reperfusion 
vasodilatation/hypovolemia, hyperdynamic circulatory state, 
and epinephrine use (during reperfusion). A delayed diagnosis 
of SAM/DLVOTO was made after TEE examination, and therapy 
was changed from inotropes to labetalol. This resulted in a rapid 
improvement of the patient’s hemodynamics. Though similar, 
the unique aspect of our case was the rapid echocardiographic 
diagnosis of SAM/DLVOTO due to our institution’s policy to use 
TEE monitoring during OLT. Even though epinephrine is the 
drug of choice for PRS treatment in many centers, liver transplant 
physicians should be cautious of the potentially detrimental effect 
of inotropes on BP during reperfusion. Likewise, they should also 
utilize TEE whenever possible to help guide the management of 
refractory hypotension.
Transesophageal echocardiographic monitoring in OLT 
is extremely useful for hemodynamic monitoring due to its 
rapid diagnostic capabilities (21). Most notably, it can assist in 
the rapid diagnosis and subsequent treatment of the following 
conditions: SAM/DLVOTO, cardiovascular thrombus formation 
and pulmonary thromboembolism, valvular dysfunction, venous 
air embolism, paradoxical embolization (in the setting of an 
intracardiac or transpulmonary shunt), and acute right ventricu-
lar failure (6–8, 11, 16, 19–22). Both the 2003 ACC/AHA/ASE 
Guideline Update for the Clinical Application of Echocardiography 
and the 2010 ASA/SCA Practice Guidelines for Perioperative TEE 
strongly recommend the use of TEE in cases associated with 
significant hemodynamic swings, which includes OLT as a Class 
I recommendation (23, 24). Nonetheless, the benefits of TEE 
monitoring should always be weighed against its potential risks, 
especially in the setting of esophageal variceal disease. The 2010 
ASA/SCA Practice Guidelines for Perioperative TEE firmly empha-
sizes this point and recommends precautionary measures, such as 
ordering a gastroenterology consultation and using a smaller TEE 
probe to prevent significant variceal bleeding (23). Needless to 
say, the safety of TEE in OLT has been characterized in multiple 
studies. In a retrospective study, Suriani et  al. reported a 2% 
complication rate while utilizing TEE in OLT patients (n = 100). 
Only two TEE-related complications were reported: bradycardia 
(n = 1) and variceal bleeding (n = 1). However, the patient with 
variceal bleeding had a history of esophageal varices and required 
sclerotherapy 4 years prior to transplantation. It is important to 
note that only three anesthesiologists performed TEE examina-
tions in this study; two were cardiothoracic anesthesiologists 
with significant TEE experience; and one was a less experienced 
anesthesiologist under the supervision of a skilled echocardiog-
rapher. The low complication rate observed in this study most 
likely resulted from a limited number of manipulations occurring 
throughout image acquisition. Another study utilized TEE in 
OLT recipients with known esophageal varices (n = 287). This 
study only reported a 0.003% variceal bleeding rate (25).
Our institution currently uses TEE in most liver transplanta-
tion surgeries, based on preoperative EGD findings. Fellowship-
trained cardiovascular anesthesiologists with adequate TEE 
experience perform both the placement of the probe and the 
TEE examination. Pre-anhepatic baseline TEE examinations 
are limited to the midesophageal views, which focus on valvular 
competency, intracardiac and transpulmonary shunts, and global 
biventricular function. The transgastric views are generally 
avoided due to the high incidence of gastropathy in patients with 
end-stage liver disease. The postreperfusion examination focuses 
primarily on global biventricular systolic function and filling, 
identifying intracardiac masses, intracardiac air, and valvular 
pathology, such as SAM.
Extensive preoperative cardiac evaluation is necessary for 
transplant recipients. This is primarily due to the high prevalence 
of coronary artery disease (2.5–27%), cardiomyopathy, and elec-
trophysiological abnormalities in this patient population (26–31). 
As part of the preoperative evaluation, a resting echocardiogram 
is recommended for every liver recipient. This helps physicians to 
assess biventricular function (systolic and diastolic), ventricular 
size and thickness, valvular function, biatrial dimension, right 
ventricular systolic pressure, intracardiac structural abnormality, 
and intrapulmonary arteriovenous malformations (26, 27). Very 
poor outcomes have been reported for OLT patients with coro-
nary artery disease (50% mortality rate and 80% morbidity rate) 
since the heart is unable to withstand the increased physiologic 
stress (28). Likewise, patients with risk factors for CAD, such as 
diabetes, hypertension, and NASH cirrhosis, should undergo 
stress testing to rule out myocardial ischemia (26, 27, 29, 30, 32).
A pharmacological stress test is preferred for assessing myo-
cardial ischemia in OLT recipients, secondary to their poor exer-
cise tolerance; however, the optimal pharmacological stress agent 
remains to be determined (26, 33). Vasodilator stressors, such 
as adenosine and dipyridamole, induce myocardial ischemia by 
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decreasing oxygen supply in the stenotic coronary arteries (steal 
phenomenon), whereas dobutamine increases oxygen demand 
through its chronotropic and inotropic effects (29, 33–35). 
Myocardial ischemia can be detected by any of these pharmaco-
logical agents, although dobutamine has proven more effective 
at inducing myocardial ischemia in patients with low-grade 
coronary artery stenosis (29, 31, 34, 36, 37). The utility of the 
vasodilator perfusion stress test in OLT recipients has been ques-
tioned since the baseline vasodilatory state is heightened in these 
patients (26). Therefore, a dobutamine stress echocardiogram 
may provide the best overall evaluation for risk stratification in 
OLT candidates. As a preoperative tool, it can assess myocardial 
ischemia and prior myocardial injury, pulmonary hypertension, 
global biventricular function, and delayed intrapulmonary 
shunting (7, 27, 30, 32). It can also induce LVOT gradients in 
patients with significant LV basal septal hypertrophy, due to its 
ability to increase cardiac output while reducing SVR (7, 27, 32).
Our patient had a benign preoperative TTE examination, so 
an adenosine technetium-99m sestamibi stress SPECT myocar-
dial perfusion imaging study was obtained to rule out coronary 
ischemia. In retrospect, a dobutamine stress echocardiogram 
would have been more ideal; however, it is unlikely that DLVOTO 
would have been induced. Instead, intraoperative TEE monitor-
ing became an invaluable tool for successfully managing this 
patient.
CoNCLUsIoNs
This case report highlights the importance of intraoperative TEE 
monitoring during OLT, and further emphasizes the utility of 
TEE in clinical decision-making. During the treatment of PRS 
with inotropes, paradoxical hypotension can result from SAM/
DLVOTO and cause catastrophic outcomes if not promptly 
diagnosed. TEE monitoring can aid the rapid diagnosis and sub-
sequent treatment of SAM/DLVOTO following the onset of PRS.
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